Showing 18,681 - 18,700 results of 32,444 for search '(( 50 ((we decrease) OR (((mean decrease) OR (a decrease)))) ) OR ( a step decrease ))', query time: 1.13s Refine Results
  1. 18681

    The abundance of glycine increases with age in <i>C</i>. <i>elegans</i>. by Yasmine J. Liu (6433946)

    Published 2019
    “…<p><b>(A)</b> Glycine metabolic pathways in <i>C</i>. …”
  2. 18682
  3. 18683

    DataSheet1_Using robot-assisted stiffness perturbations to evoke aftereffects useful to post-stroke gait rehabilitation.PDF by Vaughn Chambers (14326038)

    Published 2023
    “…Post-stroke gait normally presents as one of or a combination of unilaterally shortened step length, decreased dorsiflexion during swing phase, and decreased walking speed. …”
  4. 18684

    S5 Fig - by Pablo Capilla-Lasheras (5209658)

    Published 2024
    “…To do this, we estimated the signal strength (RSSI)-distance relationship within our study site (panel A) using biologically realistic locations for the birds via the method described below, and then calculated the mean signal strength obtained at 50 m distance from a receiver in this context for use as this threshold value (as the mean ± SE distance between neighbouring territory centres is just 93.7 m ± 4.56 m in our study population). …”
  5. 18685

    Effect of CART on motor behavior. by Peizhong Mao (189608)

    Published 2012
    “…For the Control (CTL) group, there was nearly a 50/50 split in terms of the number of free versus wall-assisted rears. …”
  6. 18686

    Table_5_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.xlsx by Michelle L. D'Antoni (8058620)

    Published 2019
    “…These data may implicate IRF-8 as a novel transcription factor in the neuropathophysiology of brain abnormalities in treated HIV and serve as a potential therapeutic target to decrease the burden of cognitive dysfunction in this population.…”
  7. 18687

    Table_2_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.xlsx by Michelle L. D'Antoni (8058620)

    Published 2019
    “…These data may implicate IRF-8 as a novel transcription factor in the neuropathophysiology of brain abnormalities in treated HIV and serve as a potential therapeutic target to decrease the burden of cognitive dysfunction in this population.…”
  8. 18688

    Table_3_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.xlsx by Michelle L. D'Antoni (8058620)

    Published 2019
    “…These data may implicate IRF-8 as a novel transcription factor in the neuropathophysiology of brain abnormalities in treated HIV and serve as a potential therapeutic target to decrease the burden of cognitive dysfunction in this population.…”
  9. 18689

    Table_1_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.xlsx by Michelle L. D'Antoni (8058620)

    Published 2019
    “…These data may implicate IRF-8 as a novel transcription factor in the neuropathophysiology of brain abnormalities in treated HIV and serve as a potential therapeutic target to decrease the burden of cognitive dysfunction in this population.…”
  10. 18690

    Table_4_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.xlsx by Michelle L. D'Antoni (8058620)

    Published 2019
    “…These data may implicate IRF-8 as a novel transcription factor in the neuropathophysiology of brain abnormalities in treated HIV and serve as a potential therapeutic target to decrease the burden of cognitive dysfunction in this population.…”
  11. 18691

    Table_6_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.xlsx by Michelle L. D'Antoni (8058620)

    Published 2019
    “…These data may implicate IRF-8 as a novel transcription factor in the neuropathophysiology of brain abnormalities in treated HIV and serve as a potential therapeutic target to decrease the burden of cognitive dysfunction in this population.…”
  12. 18692

    Image_2_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.TIF by Michelle L. D'Antoni (8058620)

    Published 2019
    “…These data may implicate IRF-8 as a novel transcription factor in the neuropathophysiology of brain abnormalities in treated HIV and serve as a potential therapeutic target to decrease the burden of cognitive dysfunction in this population.…”
  13. 18693

    Image_1_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.TIFF by Michelle L. D'Antoni (8058620)

    Published 2019
    “…These data may implicate IRF-8 as a novel transcription factor in the neuropathophysiology of brain abnormalities in treated HIV and serve as a potential therapeutic target to decrease the burden of cognitive dysfunction in this population.…”
  14. 18694

    Table_7_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.xlsx by Michelle L. D'Antoni (8058620)

    Published 2019
    “…These data may implicate IRF-8 as a novel transcription factor in the neuropathophysiology of brain abnormalities in treated HIV and serve as a potential therapeutic target to decrease the burden of cognitive dysfunction in this population.…”
  15. 18695

    Simulation-Based Parametric Study for the Hybrid Superplastic Forming of AZ31 by Al-Abtaha, Fatima Ghassan

    Published 2019
    “…The forming process consists of two steps. At the pre-forming step (deep drawing), the sheet is drawn into the die to a preselected level, using a mechanical punch, and at the second step (SPF) a pressurized gas is applied at a controlled rate. …”
    Get full text
    Get full text
  16. 18696

    Global Consumption Trend of Antifungal Agents in Humans From 2008 to 2018: Data From 65 Middle- and High-Income Countries by Pathadka, Swathi

    Published 2022
    “…Results: Consumption of systemic antifungal agents increased from 0.50 (in 2008) to 0.92 defined daily dose (DDD)/1000 inhabitants/day (in 2018), with a compound annual growth rate of 6.2%. …”
    Get full text
    Get full text
    Get full text
  17. 18697

    DataSheet_1_E2F1 mediates competition, proliferation and response to cisplatin in cohabitating resistant and sensitive ovarian cancer cells.docx by Andres Valdivia (16546941)

    Published 2024
    “…Direct co-culture led to a decrease in the IC50 to platinum in the cisplatin-sensitive cells (5.92 µM to 2.79 µM for PE01, and from 2.05 µM to 1.51 µM for OVCAR5). …”
  18. 18698

    Data_Sheet_1_Large Gatherings? No, Thank You. Devaluation of Crowded Social Scenes During the COVID-19 Pandemic.pdf by Claudia Massaccesi (10898715)

    Published 2021
    “…Even people not directly affected by the virus itself were impacted in their physical and/or mental health, as well as in their financial security, by governmental lockdown measures. We investigated whether the combination of these events had changed people's appraisal of social scenes by testing 241 participants recruited mainly in Italy, Austria, and Germany in an online, preregistered study conducted about 50 days after the beginning of the COVID-19 outbreak in Europe. …”
  19. 18699

    Data_Sheet_1_Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies.pdf by Eli Hatchwell (8584452)

    Published 2022
    “…</p>Conclusion<p>For the first time, a PML genetic risk test can be implemented for screening patients taking or considering treatment with a PML-linked drug in order to decrease the incidence of PML and enable safer use of highly effective therapies used to treat their underlying disease.…”
  20. 18700